Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of KLS-GABA vs KLS in Healthy Males
NCT04802967Phase 1Completed
- Sponsor
- Dompé
- Start
- Feb 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ketoprofen and gabapentin in chronic pain and neuropathic pain (6 arms), sponsored by Dompé. Primary endpoints: Area Under the Concentration-time Curve From Zero to Last Quantifiable Concentration, Area Under the Concentration-time Curve From Zero to 12 Hours and 2 more. Started Feb 2021; status: completed.
02
Drugs
ketoprofengabapentin
03
Conditions
chronic painneuropathic pain
Beyond the preview
Go deeper on NCT04802967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04802967.